| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147578 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147494 Use |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040146951 from pancreas cells; for drug screening compounds that also bind to somatostatin type-5 receptor ("SSTR-5") |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 07/29/2004 | DE10303671A1 New 8alpha,14beta-dialkyl-18-nor steroids useful as pharmaceuticals, intermediates or carriers for treating e.g. tumors, alzheimers disease |
| 07/29/2004 | DE10303667A1 New 14-fluoro-15,17-dihydroxysteroid derivatives, useful for treating Alzheimer's disease and tumors, and as intermediates, are e.g. inhibitors of steroid dehydrogenase |
| 07/29/2004 | CA2513300A1 Obesity-related genes |
| 07/29/2004 | CA2513277A1 Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440052A1 Benzamide derivatives as antagonists of orexin receptors |
| 07/28/2004 | EP1439854A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0861073B1 Stabilized thyroid hormone preparations and methods of making same |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516606A Dry powder inhalation system for transpulmonary administration |
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
| 07/28/2004 | CN1516589A N-biphenylcarbonyl-anjd N-phenylpyridylcarbonyl substituted bi-and tricyclic azepines and diazepines as vasopressing agonists |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1515570A Preparation method of pyrazolo [4,3-C] pyridine-3-ketone L-tartate |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515257A Paroxetine control-released composite |
| 07/28/2004 | CN1159341C Method of treatment of corticosteroid induced osteopenia |
| 07/28/2004 | CN1159337C Steroides sulfatase inhibitors and methos for making and using same |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/28/2004 | CN1159062C Pharmaceutical compositions of peptides having low solubility in physiological medium |
| 07/27/2004 | US6768026 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | US6767531 High dose radionuclide complexes for bone marrow suppression |
| 07/22/2004 | WO2004061091A2 Insulin producing cells |
| 07/22/2004 | WO2004060488A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/22/2004 | WO2004060391A1 Use of somatostatin analogs in sleep apnea |
| 07/22/2004 | WO2004060316A2 Irs modulators |
| 07/22/2004 | WO2004039978A3 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040143008 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 07/22/2004 | US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 07/22/2004 | US20040142987 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
| 07/22/2004 | US20040142935 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor liqands and/or serotonergic ligands |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142901 Production of pancreatic islet cells and delivery of insulin |
| 07/22/2004 | US20040142879 Use of the acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus |
| 07/22/2004 | US20040142850 Benzimidazolidinone derivatives |
| 07/22/2004 | US20040142031 carrier containing more than 10% by weight of a water-insoluble starch; shelf-life under relatively dry circumstances is enhanced. |
| 07/22/2004 | US20040142030 Stabilized tibolone compositions |
| 07/22/2004 | US20040142028 carrier containing more than 10% by weight of a water-insoluble starch; shelf-life under relatively dry circumstances is enhanced. |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | CA2515518A1 Irs modulators |
| 07/22/2004 | CA2509758A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/21/2004 | EP1438957A1 Benzothiophene formulations of a specific dosage |
| 07/21/2004 | EP1438583A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1438336A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438043A2 Method of reducing type 2 diabetes in high risk patients |
| 07/21/2004 | EP1438038A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 07/21/2004 | EP1357977B1 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP0815224B1 Receptor activation by gas6 |
| 07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
| 07/21/2004 | CN1514834A Cyclohexylphenyl vasopression agonists |
| 07/21/2004 | CN1514732A Pharmaceutical formulation consisting of plant extract with calcium coating |
| 07/21/2004 | CN1158305C Insulin derivatives with increased zinc binding |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158075C Pharmaceutical compsn. and process for its prepn. |
| 07/20/2004 | US6765014 1-Acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 07/15/2004 | WO2004058298A1 Immunotherapy of b cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
| 07/15/2004 | WO2003092588A3 4-azasteroid derivatives as androgen receptor modulators |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138314 Reduction of breast density with 4-hydroxy tamoxifen |
| 07/15/2004 | US20040138305 Alpha2delta ligands for the treatment of fibromyalgia and other disorders |
| 07/15/2004 | US20040138303 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone |
| 07/15/2004 | US20040138297 Administering bicyclic diterpene compound of the labdane to treat menstrual disorders and premenstrual syndrome |
| 07/15/2004 | US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 07/15/2004 | US20040138226 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |